Search results

Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care

How to register with us as a diagnostic technologies stakeholder.

How to register with us as a diagnostic technologies stakeholder.

Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women.

Result type

Technology appraisal guidance

Last updated

7 February 2018

This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance

Early value assessment (EVA) guidance on artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning in people having external beam radiotherapy.

Result type

HealthTech guidance

Published

27 September 2023

NICE has developed a medtech innovation briefing (MIB) on Peptest for diagnosing gastro-oesophageal reflux

Result type

Medtech innovation briefing

Published

22 May 2015

Evidence-based recommendations on omalizumab (Xolair) for treating severe chronic spontaneous urticaria in people of 12 and over.

Result type

Technology appraisal guidance

Published

8 June 2015

Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic non-small-cell-lung cancer.

Result type

HealthTech guidance

Published

14 August 2013

NICE has developed a medtech innovation briefing (MIB) on Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia .

Result type

Medtech innovation briefing

Published

31 January 2023

have produced treatment pathways bringing together NICE recommended treatment options from this guideline and relevant...

Evidence-based recommendations on carmustine implants (Gliadel) and temozolomide for treating newly diagnosed high-grade glioma in adults.

Result type

Technology appraisal guidance

Published

27 June 2007

Evidence-based recommendations on panobinostat (Farydak) for treating multiple myeloma after at least 2 previous treatments.

Result type

Technology appraisal guidance

Published

27 January 2016

trials of the medium term (2–10 years) benefit of medicines recommended in guidelines for preventing future morbidity or mortality,...

Result type

Research recommendation

Published

18 October 2016

NICE has developed a medtech innovation briefing (MIB) on OrganOx metra for liver transplant .

Result type

Medtech innovation briefing

Published

14 September 2021